What are the characteristics and management of nitrofurantoin-induced pulmonary fibrosis?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901757127294976 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Nitrofurantoin-induced pulmonary fibrosis is an uncommon but serious adverse effect, mainly associated with long-term therapy. Early detection and discontinuation of the drug are critical steps in its management. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17680518 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the characteristics and management of nitrofurantoin-induced pulmonary fibrosis? Tripdatabase characteristics management nitrofurantoin induced pulmonary fibrosis Nitrofurantoin-induced pulmonary fibrosis is an uncommon but serious adverse effect, mainly associated with long-term therapy. Early detection and discontinuation of the drug are critical steps in its management. |
| title | What are the characteristics and management of nitrofurantoin-induced pulmonary fibrosis? |
| topic | characteristics management nitrofurantoin induced pulmonary fibrosis |
| url | https://doi.org/10.5281/zenodo.17680518 |